0,890  0,007  Apoptosis agonist
0,871  0,007  Antiinflammatory
0,868  0,005  Antineoplastic (breast cancer)
0,842  0,005  Antileukemic
0,834  0,007  Caspase 9 stimulant
0,803  0,004  Nitric oxide antagonist
0,801  0,008  Antineoplastic (lung cancer)
0,768  0,005  Bone diseases treatment
0,763  0,009  Antineoplastic (colorectal cancer)
0,762  0,009  Antineoplastic (colon cancer)
0,744  0,005  Antipsoriatic
0,730  0,005  Antineoplastic (melanoma)
0,733  0,011  TNF expression inhibitor
0,719  0,005  Antiosteoporotic
0,718  0,019  Transcription factor NF kappa B inhibitor
0,697  0,009  Sensitization
0,686  0,005  Antineoplastic (pancreatic cancer)
0,685  0,007  Cardiovascular analeptic
0,681  0,005  Antineoplastic (glioma)
0,682  0,011  Prostate cancer treatment
0,673  0,005  Antineoplastic (multiple myeloma)
0,625  0,009  Hepatic disorders treatment
0,614  0,004  Antiacne
0,606  0,005  Antineoplastic (glioblastoma multiforme)
0,612  0,014  Antineoplastic (ovarian cancer)
0,608  0,010  Antipruritic, allergic
0,598  0,004  Prostatic (benign) hyperplasia treatment
0,583  0,005  Hair growth stimulant
0,585  0,009  Antipyretic
0,583  0,011  Caspase 3 stimulant
0,575  0,007  Antineoplastic (lymphoma)
0,566  0,003  Abortion inducer
0,562  0,005  Antineoplastic (liver cancer)
0,558  0,013  Antineoplastic (brain cancer)
0,560  0,027  Teratogen
0,540  0,008  Antineoplastic (endocrine cancer)
0,547  0,021  Immunosuppressant
0,527  0,006  Hepatoprotectant
0,539  0,024  Respiratory analeptic
0,516  0,004  Calcium channel activator
0,513  0,004  Prostate disorders treatment
0,514  0,006  Transcription factor STAT3 inhibitor
0,511  0,005  Contraceptive
0,514  0,009  Antineoplastic (renal cancer)
0,503  0,006  Interferon gamma antagonist
0,501  0,008  Transcription factor STAT inhibitor
0,516  0,029  Embryotoxic
0,493  0,012  Antineoplastic enhancer
0,492  0,026  Cytotoxic
0,480  0,021  NOS2 expression inhibitor
0,481  0,023  AR expression inhibitor
0,460  0,004  Antipruritic, non-allergic
0,475  0,021  Chemopreventive
0,466  0,025  NOS3 expression inhibitor
0,459  0,021  ICAM1 expression inhibitor
0,460  0,022  Antiprotozoal (Leishmania)
0,424  0,011  Sodium/bile acid cotransporter inhibitor
0,443  0,033  Antifungal
0,417  0,008  Antialcoholic
0,412  0,010  UGT2B7 substrate
0,429  0,032  Analeptic
0,394  0,004  Contraceptive female
0,401  0,014  Antiparkinsonian, rigidity relieving
0,414  0,030  Antineoplastic (non-small cell lung cancer)
0,402  0,019  Antineoplastic (lymphocytic leukemia)
0,420  0,038  CYP2C19 substrate
0,384  0,004  TRPA1 agonist
0,409  0,036  Apoptosis antagonist
0,394  0,023  Angiogenesis stimulant
0,393  0,023  Antineoplastic (osteosarcoma)
0,384  0,018  Growth hormone agonist
0,374  0,009  Antiviral (Influenza A)
0,425  0,066  Antibacterial
0,393  0,037  Antineoplastic (cervical cancer)
0,414  0,059  CYP3A4 substrate
0,369  0,016  Platelet adhesion inhibitor
0,383  0,032  Proliferative diseases treatment
0,382  0,030  Tumour necrosis factor alpha release inhibitor
0,368  0,019  UGT1A4 substrate
0,335  0,003  Transcription factor NF kappa B stimulant
0,349  0,019  Antiviral (Influenza)
0,340  0,010  Neurotrophic factor enhancer
0,335  0,006  Androgen antagonist
0,363  0,035  Antihypoxic
0,335  0,008  Antifungal enhancer
0,330  0,005  Farnesoid X receptor antagonist
0,359  0,041  UGT2B4 substrate
0,340  0,024  Antihelmintic
0,317  0,003  Hypercalcemia treatment
0,346  0,034  Antiparasitic
0,350  0,044  Chemoprotective
0,376  0,071  CYP2C9 substrate
0,332  0,031  5 Hydroxytryptamine uptake stimulant
0,281  0,004  5-Alpha-reductase inhibitor
0,288  0,013  Cholesterol synthesis inhibitor
0,277  0,004  CDC25A inhibitor
0,294  0,022  Lipocortins synthesis antagonist
0,324  0,056  Antihypercholesterolemic
0,290  0,025  Pneumotoxic
0,286  0,022  Protein-tyrosine phosphatase inhibitor
0,263  0,005  ABCA1 expression enhancer
0,301  0,043  DNA synthesis inhibitor
0,272  0,016  Antineoplastic (bone cancer)
0,269  0,014  Protein-tyrosine phosphatase 1B inhibitor
0,260  0,008  Choleretic
0,317  0,065  5 Hydroxytryptamine release stimulant
0,296  0,044  Antiulcerative
0,252  0,004  Bile acid receptor antagonist
0,297  0,049  Interleukin agonist
0,279  0,037  UGT1A1 substrate
0,249  0,009  Microtubule formation inhibitor
0,245  0,005  Actinic keratosis treatment
0,298  0,062  Antioxidant
0,271  0,039  RNA-directed DNA polymerase inhibitor
0,236  0,005  Adenylate cyclase stimulant
0,265  0,037  Non-steroidal antiinflammatory agent
0,253  0,025  Protein kinase stimulant
0,311  0,084  Cholesterol antagonist
0,267  0,044  UDP-glucuronosyltransferase substrate
0,226  0,005  Lipase inhibitor
0,266  0,045  Sigma receptor agonist
0,254  0,035  CYP2B6 inhibitor
0,230  0,011  Arachidonic acid antagonist
0,221  0,004  Progesterone antagonist
0,219  0,007  Pregnane X receptor agonist
0,214  0,004  Paget's disease treatment
0,291  0,081  Immunostimulant
0,233  0,025  UGT2B9 substrate
0,209  0,002  Vitamin D receptor antagonist
0,235  0,029  LDLR expression enhancer
0,206  0,005  Antiviral (SARS coronavirus)
0,206  0,005  Antiviral (Coronavirus)
0,205  0,004  Hyperparathyroidism treatment
0,207  0,008  Inducible nitric-oxide synthase inhibitor
0,221  0,024  UGT2B10 substrate
0,219  0,024  Antiviral (Hepatitis B)
0,197  0,002  Postcoital contraceptive
0,200  0,008  Keratolytic
0,193  0,005  Anabolic
0,186  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,212  0,033  Bone formation stimulant
0,179  0,004  Potassium channel Kv1.3 blocker
0,222  0,047  Muscle relaxant
0,188  0,017  Antineoplastic alkaloid
0,174  0,003  Na+ K+ transporting ATPase inhibitor
0,208  0,038  Acute respiratory distress syndrome (ARDS) treatment
0,183  0,017  Vanilloid 1 agonist
0,227  0,061  Carcinogenic
0,206  0,042  Antineoplastic (carcinoma)
0,212  0,049  Diabetic nephropathy treatment
0,186  0,023  Antineoplastic antibiotic
0,180  0,017  Antiinfertility, female
0,203  0,041  Antineoplastic (squamous cell carcinoma)
0,269  0,109  FMO1 substrate
0,245  0,085  Gastrin inhibitor
0,170  0,011  Aromatase inhibitor
0,234  0,075  Cytostatic
0,198  0,042  Interleukin 6 antagonist
0,158  0,003  Heme oxygenase stimulant
0,158  0,005  Aldosterone antagonist
0,194  0,045  Antirickettsial
0,159  0,012  UGT2B11 substrate
0,156  0,015  Contraceptive male
0,194  0,053  Liver fibrosis treatment
0,229  0,088  Antineoplastic (sarcoma)
0,191  0,050  Antiviral (Herpes)
0,143  0,007  Narcotic antagonist
0,157  0,021  Antispirochetal
0,163  0,027  Alcohol dehydrogenase substrate
0,143  0,008  Androgen agonist
0,131  0,002  Parathyroid hormone antagonist
0,167  0,039  Antieczematic
0,234  0,106  Cardioprotectant
0,141  0,013  Postmenopausal disorders treatment
0,192  0,066  Antiviral (Hepatitis)
0,171  0,049  Antidiabetic (type 1)
0,175  0,057  Diuretic
0,131  0,013  Glycine receptor antagonist
0,173  0,056  Melanin inhibitor
0,118  0,001  Progesterone receptor B antagonist
0,159  0,043  Retinoprotector
0,217  0,103  DNA damaging
0,115  0,004  Anesthetic inhalation
0,139  0,028  Nitric-oxide synthase inhibitor
0,190  0,080  Anesthetic general
0,176  0,066  Toxic, respiratory center
0,198  0,092  Cardiodepressant
0,217  0,112  Radioprotector
0,173  0,069  Phospholipase C inhibitor
0,196  0,092  VCAM1 expression inhibitor
0,160  0,057  Anesthetic
0,163  0,061  UGT2B15 substrate
0,152  0,052  Cocaine dependence treatment
0,119  0,018  Nicotinic alpha4beta2 receptor antagonist
0,158  0,058  Skeletal muscle relaxant
0,101  0,004  Retinoid X gamma receptor agonist
0,100  0,003  ATP citrate lysase inhibitor
0,121  0,025  Ornithine decarboxylase inhibitor
0,111  0,015  Glycine receptor agonist
0,240  0,144  Vasodilator, coronary
0,201  0,106  Antihypotensive
0,203  0,110  Hypoglycemic
0,227  0,135  CTGF expression inhibitor
0,140  0,049  Growth stimulant
0,095  0,005  Adenylate cyclase 1 inhibitor
0,156  0,066  CF transmembrane conductance regulator agonist
0,301  0,212  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,104  0,016  Anticholelithogenic
0,162  0,074  UGT1A3 substrate
0,139  0,052  Adenylate cyclase inhibitor
0,089  0,003  CYP24 inhibitor
0,229  0,145  Vasodilator, peripheral
0,116  0,033  SULT1E1 substrate
0,253  0,170  CYP2C19 inhibitor
0,111  0,029  Glutamate release inhibitor
0,221  0,141  Immunomodulator
0,109  0,030  Tocolytic
0,131  0,052  Menstruation disorders treatment
0,088  0,009  Lipocortins synthesis agonist
0,091  0,014  SULT2A1 substrate
0,083  0,008  RNA-directed RNA polymerase stimulant
0,082  0,006  Glucocorticoid antagonist
0,204  0,129  Renal disease treatment
0,154  0,080  Uterine stimulant
0,162  0,089  Antineoplastic (gastric cancer)
0,077  0,004  Retinoid X beta receptor agonist
0,166  0,094  P-glycoprotein inhibitor
0,080  0,008  Retinoid X receptor agonist
0,134  0,063  Antihyperlipoproteinemic
0,102  0,031  Vanilloid agonist
0,084  0,015  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,076  0,008  Retinoid X alpha receptor agonist
0,075  0,008  Liver X receptor alpha agonist
0,111  0,045  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,102  0,038  Acetylcholine nicotinic antagonist
0,095  0,030  T cell inhibitor
0,085  0,021  Estrogen agonist
0,179  0,116  UGT1A6 substrate
0,098  0,036  3C-Like protease (SARS coronavirus) inhibitor
0,218  0,156  GST M1-1 substrate
0,243  0,183  Antineoplastic (myeloid leukemia)
0,123  0,066  DNA polymerase I inhibitor
0,059  0,002  Progesterone receptor A antagonist
0,080  0,024  Glutamate (mGluR6) antagonist
0,149  0,095  Antipruritic
0,101  0,048  Antiviral (Rhinovirus)
0,118  0,067  Proteasome inhibitor
0,072  0,020  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,062  0,012  Microtubule stabilization
0,135  0,085  Antifungal (Cryptococcus)
0,185  0,136  Lipoprotein disorders treatment
0,056  0,009  Glucose-6-phosphate dehydrogenase inhibitor
0,054  0,007  Tubulin agonist
0,062  0,015  Cholesterol esterase inhibitor
0,091  0,044  Opioid kappa receptor antagonist
0,053  0,007  5-Alpha-reductase 2 inhibitor
0,076  0,031  CDC25B inhibitor
0,131  0,086  Antimutagenic
0,056  0,012  Farnesoid X receptor agonist
0,048  0,005  Retinoic acid receptor agonist
0,106  0,063  UGT2B1 substrate
0,123  0,080  Antihemorrhagic
0,047  0,005  Progesterone agonist
0,085  0,043  Antibiotic
0,161  0,119  Insulin sensitizer
0,071  0,030  Antimycoplasmal
0,059  0,018  Opioid kappa receptor agonist
0,054  0,013  GABA uptake inhibitor
0,053  0,012  Retinoic acid alpha receptor agonist
0,051  0,011  Retinoid X receptor antagonist
0,119  0,079  Antismoking
0,105  0,065  Antiprotozoal (Toxoplasma)
0,060  0,020  Mineralocorticoid receptor antagonist
0,076  0,036  Bcl2 antagonist
0,101  0,062  Sulfotransferase substrate
0,043  0,004  Retinoid X gamma receptor antagonist
0,126  0,087  CC chemokine 6 receptor antagonist
0,042  0,004  NMDA receptor phencyclidine site antagonist
0,055  0,017  Geranyltranstransferase inhibitor
0,044  0,007  5-Alpha-reductase 1 inhibitor
0,040  0,004  Retinoic acid gamma receptor agonist
0,102  0,066  Expectorant
0,045  0,010  Retinoid X alpha receptor antagonist
0,043  0,008  Liver X receptor alpha antagonist
0,055  0,019  Liver X receptor agonist
0,110  0,075  Estrogen antagonist
0,047  0,013  Cholesterol absorption inhibitor
0,092  0,059  Thioredoxin inhibitor
0,062  0,029  Protein 50S ribosomal subunit inhibitor
0,067  0,034  Transcription factor AP-1 inhibitor
0,061  0,029  Pregnane X receptor antagonist
0,044  0,012  Liver X receptor antagonist
0,043  0,011  Liver X receptor beta antagonist
0,149  0,117  Psychostimulant
0,102  0,071  GST T1-1 substrate
0,118  0,088  Skin whitener
0,034  0,004  Retinoid X beta receptor antagonist
0,038  0,009  Estrone sulfatase inhibitor
0,032  0,004  Vitamin D receptor agonist
0,202  0,174  Antithrombotic
0,033  0,005  Retinoic acid beta receptor agonist
0,033  0,005  Corticosteroid-like
0,048  0,020  Alpha 1L adrenoreceptor agonist
0,145  0,118  Catenin beta inhibitor
0,060  0,032  Acetyl-CoA transferase 2 inhibitor
0,043  0,017  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,092  0,069  Anticataract
0,029  0,007  Retinoic acid alpha receptor antagonist
0,031  0,010  Hedgehog signaling activator
0,021  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,092  0,074  Tourette's syndrome treatment
0,035  0,017  Cholesterol ester transfer protein antagonist
0,025  0,008  Retinoic acid receptor antagonist
0,053  0,037  Nicotinic alpha3beta2 receptor antagonist
0,131  0,115  Ca2+-transporting ATPase inhibitor
0,079  0,063  Antiprotozoal activity enhancer
0,089  0,074  Lanosterol 14 alpha demethylase inhibitor
0,029  0,015  Nicotinic acid receptor 2 antagonist
0,034  0,020  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,013  0,001  Vitamin D-like
0,073  0,062  Estrogen receptor alpha antagonist
0,120  0,109  Genotoxic
0,122  0,111  Eye irritation, high
0,023  0,012  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,071  0,062  Vanilloid 4 agonist
0,018  0,011  Telomerase stimulant
0,097  0,090  Carcinogenic, group 3
0,032  0,025  Liver X receptor beta agonist
0,013  0,007  Retinoic acid receptor gamma antagonist
0,061  0,055  Uterine relaxant
0,114  0,109  Mutagenic
0,029  0,024  Estrogen receptor beta agonist
0,014  0,009  Glucocorticoid agonist
0,039  0,034  Kainate receptor agonist
0,031  0,026  Estrogen receptor alpha agonist
0,031  0,026  Glutamate (mGluR3) agonist
0,045  0,040  Cannabinoid CB2 receptor antagonist
0,056  0,052  Ryanodine receptor antagonist
0,036  0,032  Glutamate (mGluR8) agonist
0,048  0,045  Acyl-CoA dehydrogenase inhibitor
0,012  0,008  Retinoic acid beta receptor antagonist
0,096  0,093  Alkylator
0,019  0,016  Antibiotic Quinolone-like
0,093  0,090  SULT1A1 substrate
0,036  0,034  Membrane dipeptidase inhibitor
0,128  0,126  Sedative
0,023  0,022  Vanilloid 2 agonist
0,039  0,038  Nicotinic receptor alpha3 subunit antagonist

